OpenURL Connection Search

Select item for more details and to access through your institution.

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia.
Published in:
International Journal of Hematology, 2014, v. 100, n. 6, p. 567, doi. 10.1007/s12185-014-1685-9
By:
- Sweet, Kendra;
- Al Ali, Najla;
- Dalia, Samir;
- Komrokji, Rami;
- Crescentini, Robert;
- Tinsley, Sara;
- Lancet, Jeffrey;
- Papenhausen, Peter;
- Zhang, Ling;
- Pinilla-Ibarz, Javier
Publication type:
Article
Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapy.
Published in:
2022
By:
- Oswald, Laura B.;
- Hyland, Kelly A.;
- Eisel, Sarah L.;
- Hoogland, Aasha I.;
- Knoop, Hans;
- Nelson, Ashley M.;
- Pinilla-Ibarz, Javier;
- Sweet, Kendra;
- Jacobsen, Paul B.;
- Jim, Heather S. L.
Publication type:
journal article
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes.
Published in:
British Journal of Haematology, 2022, v. 198, n. 4, p. 713, doi. 10.1111/bjh.18319
By:
- Volpe, Virginia O.;
- Al Ali, Najla;
- Chan, Onyee;
- Padron, Eric;
- Sallman, David A.;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia.
Published in:
American Journal of Hematology, 2023, v. 98, n. 12, p. E360, doi. 10.1002/ajh.27092
By:
- Patel, Parth C.;
- Ball, Somedeb;
- Jain, Akriti G.;
- Wang, Chen;
- Hussaini, Mohammad O.;
- Aguirre, Luis E.;
- Chan, Onyee;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Published in:
American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Aguirre, Luis E.;
- Al Ali, Najla;
- Zhang, Yumeng;
- Chan, Onyee;
- Kuykendall, Andrew T.;
- Sweet, Kendra L.;
- Lancet, Jeffrey E.;
- Swoboda, David M.;
- Padron, Eric;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia: A Pilot Study.
Published in:
2022
By:
- Hyland, Kelly A;
- Nelson, Ashley M;
- Eisel, Sarah L;
- Hoogland, Aasha I;
- Ibarz-Pinilla, Javier;
- Sweet, Kendra;
- Jacobsen, Paul B;
- Knoop, Hans;
- Jim, Heather S L
Publication type:
journal article
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia.
Published in:
Annals of Hematology, 2024, v. 103, n. 9, p. 3429, doi. 10.1007/s00277-024-05851-4
By:
- Lipton, Jeffrey H.;
- Brümmendorf, Tim H.;
- Sweet, Kendra;
- Apperley, Jane F.;
- Cortes, Jorge E.
Publication type:
Article
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.
Published in:
Annals of Hematology, 2024, v. 103, n. 6, p. 1941, doi. 10.1007/s00277-024-05760-6
By:
- Jain, Akriti G;
- Gesiotto, Quinto;
- Ball, Somedeb;
- Nodzon, Lisa;
- Rodriguez, Amanda;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David A.;
- Lancet, Jeffrey E;
- Pinilla-Ibarz, Javier;
- Sweet, Kendra
Publication type:
Article
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
Published in:
Annals of Hematology, 2020, v. 99, n. 9, p. 2119, doi. 10.1007/s00277-020-04179-z
By:
- Duong, Vu H.;
- Begna, Kebede H.;
- Kashanian, Sarah;
- Sweet, Kendra;
- Wang, Eunice S.;
- Caddell, Ryan;
- Shafer, Danielle A.;
- Singh, Zeba N.;
- Baer, Maria R.;
- Al-Kali, Aref
Publication type:
Article
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation.
Published in:
2018
By:
- Kuykendall, Andrew T.;
- Shah, Savan;
- Talati, Chetasi;
- Al Ali, Najla;
- Sweet, Kendra;
- Padron, Eric;
- Sallman, David A.;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Zuckerman, Kenneth S.;
- Komrokji, Rami S.
Publication type:
journal article
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison.
Published in:
Supportive Care in Cancer, 2013, v. 21, n. 4, p. 1097, doi. 10.1007/s00520-012-1630-5
By:
- Phillips, Kristin;
- Pinilla-Ibarz, Javier;
- Sotomayor, Eduardo;
- Lee, Morgan;
- Jim, Heather;
- Small, Brent;
- Sokol, Lubomir;
- Lancet, Jeffrey;
- Tinsley, Sara;
- Sweet, Kendra;
- Komrokji, Rami;
- Jacobsen, Paul
Publication type:
Article
Exploring treatment decision-making in chronic myeloid leukemia in chronic phase.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369246
By:
- Andorsky, David;
- Kota, Vamsi;
- Sweet, Kendra
Publication type:
Article
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 459, doi. 10.1016/j.clml.2024.03.001
By:
- Aguirre, Luis E.;
- Jain, Akriti;
- Ball, Somedeb;
- Ali, Najla Al;
- Volpe, Virginia O.;
- Tinsley-Vance, Sara;
- Sallman, David;
- Sweet, Kendra;
- Lancet, Jeffrey;
- Padron, Eric;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Komrokji, Rami
Publication type:
Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
By:
- Ionescu, Filip;
- David, Jerel C.;
- Ravichandran, Apoorva;
- Sallman, David A.;
- Sweet, Kendra;
- Komrokji, Rami S.;
- Chan, Onyee;
- Kuykendall, Andrew;
- Padron, Eric;
- Faramand, Rawan;
- Bejanyan, Nelli;
- Khimani, Farhad;
- Elmariah, Hany;
- Pidala, Joseph;
- Mishra, Asmita;
- Perez, Lia;
- Nishihori, Taiga;
- Lancet, Jeffrey E.
Publication type:
Article
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
By:
- Jain, Akriti G.;
- Ball, Somedeb;
- Aguirre, Luis E.;
- Tobon, Katherine A.;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David;
- Lancet, Jeffrey E.;
- Sweet, Kendra
Publication type:
Article
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 355, doi. 10.1016/j.clml.2023.01.007
By:
- Tinsley-Vance, Sara M;
- Ali, Najla Al;
- Ball, Somedeb;
- Aguirre, Luis E;
- Jain, Akriti G;
- Hussaini, Mohammad Omar;
- Chan, Onyee;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Lancet, Jeffrey;
- Padron, Eric;
- Sallman, David A;
- Komrokji, Rami S
Publication type:
Article
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 774, doi. 10.1016/j.clml.2022.06.001
By:
- Lee, Dasom;
- Jain, Akriti G;
- Deutsch, Yehuda;
- Eatrides, Jennifer;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Lancet, Jeffrey;
- Sallman, David;
- Talati, Chetasi;
- Sweet, Kendra
Publication type:
Article
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e521, doi. 10.1016/j.clml.2022.01.015
By:
- Tokumori, Franco Castillo;
- Ali, Najla Al;
- Chan, Onyee;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew T.
Publication type:
Article
MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01825-5
By:
- Tokumori, Franco Castillo;
- Talati, Chetasi;
- Ali, Najla Al;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew
Publication type:
Article
MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01826-7
By:
- Horvat, Nathan P.;
- Komrokji, Rami;
- Ali, Najla Al;
- Talati, Chetasi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Chan, Onyee;
- Lancet, Jeffrey;
- Kuykendall, Andrew T.
Publication type:
Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S341, doi. 10.1016/S2152-2650(21)01794-8
By:
- Ali, Najla Al;
- Sallman, David;
- Onyee Chan;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S309, doi. 10.1016/S2152-2650(21)01733-X
By:
- Chan, Onyee;
- Ali, Najla Al;
- Yun, Seongseok;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Komrokji, Rami;
- Lancet, Jeffrey
Publication type:
Article
AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S293, doi. 10.1016/S2152-2650(21)01700-6
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Al Ali, Najla;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S286, doi. 10.1016/S2152-2650(21)01686-4
By:
- Volpe, Virginia;
- Vincelette, Nicole;
- Logothetis, Constantine;
- Onyee Chan;
- Talati, Chetasi;
- Sweet, Kendra;
- Calon, Gregoire;
- Horvat, Nathan;
- Kuykendall, Andrew;
- Sallman, David;
- Padron, Eric;
- Komrokji, Rami;
- Ling Zhang;
- Lancet, Jeffrey;
- Seongseok Yun
Publication type:
Article
Poster: MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01460-9
By:
- Horvat, Nathan P.;
- Komrokji, Rami;
- Ali, Najla Al;
- Talati, Chetasi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Onyee Chan;
- Lancet, Jeffrey;
- Kuykendall, Andrew T.
Publication type:
Article
Poster: MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01459-2
By:
- Tokumori, Franco Castillo;
- Talati, Chetasi;
- Ali, Najla Al;
- Sallman, David;
- Seongseok Yun;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew
Publication type:
Article
Poster: MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01428-2
By:
- Al Ali, Najla;
- Sallman, David;
- Onyee Chan;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Al Ali, Najla;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S214, doi. 10.1016/S2152-2650(21)01345-8
By:
- Chan, Onyee;
- Ali, Najla Al;
- Yun, Seongseok;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Komrokji, Rami;
- Lancet, Jeffrey
Publication type:
Article
Poster: AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01340-9
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Ali, Najla Al;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E.;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Poster: AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01331-8
By:
- Volpe, Virginia;
- Vincelette, Nicole;
- Logothetis, Constantine;
- Chan, Onyee;
- Talati, Chetasi;
- Sweet, Kendra;
- Calon, Gregoire;
- Horvat, Nathan;
- Kuykendall, Andrew;
- Sallman, David;
- Padron, Eric;
- Komrokji, Rami;
- Zhang, Ling;
- Lancet, Jeffrey;
- Yun, Seongseok
Publication type:
Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Published in:
2021
By:
- Gesiotto, Quinto J.;
- Swoboda, David M.;
- Shallis, Rory M.;
- Al Ali, Najla;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Song, Jinming;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Zeidan, Amer M.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Published in:
2021
By:
- Schwabkey, Zaker I.;
- Al Ali, Najla;
- Chan, Onyee;
- Sallman, David A.;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
journal article
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
Published in:
2020
By:
- Castillo-Tokumori, Franco;
- Talati, Chetasi;
- Al Ali, Najla;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew T.
Publication type:
journal article
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.
Published in:
2020
By:
- Melody, Megan;
- Al Ali, Najla;
- Zhang, Ling;
- Ramadan, Hanadi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Lancet, Jeffrey;
- List, Alan;
- Bennett, John M.;
- Komrokji, Rami
Publication type:
journal article
Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
Published in:
2020
By:
- Melody, Megan;
- Kuykendall, Andrew;
- Sallman, David;
- Al Ali, Najla;
- Zhang, Ling;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Extermann, Martine;
- List, Alan;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
journal article
Lenalidomide and Thalidomide are Active in MF-Related Anemia, but Differ in Duration of Response and Association of Benefit with Outcome.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S350, doi. 10.1016/j.clml.2019.07.363
By:
- Kuykendall, Andrew;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
Hypoplastic MDS in the Elderly: A Single Institutional Experience.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.344
By:
- Wang, Emilie;
- Al Ali, Najla;
- Sallman, David;
- Padron, Eric;
- Kuykendall, Andrew;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey;
- List, Alan;
- Komrokji, Rami
Publication type:
Article
Venetoclax Combination with Hypomethylating Agents for Treatment of Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S339, doi. 10.1016/j.clml.2019.07.340
By:
- Al Ali, Najla;
- Sallman, David;
- Nelson, Rebecca;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- List, Alan;
- Komrokji, Rami
Publication type:
Article
RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S233, doi. 10.1016/j.clml.2019.07.119
By:
- Chan, Onyee;
- Jennings, Michelle;
- Asghari, Hannah;
- Song, Jinming;
- Hussaini, Mohammad;
- Sallman, David;
- Padron, Eric;
- Komrokji, Rami;
- List, Alan;
- Lancet, Jeffrey;
- Mishra, Asmita;
- Sweet, Kendra;
- Talati, Chetasi
Publication type:
Article
Impact of the Number of Consolidation Chemotherapy Cycles Prior to Allogeneic Stem Cell Transplant for Adults with Acute Myeloid Leukemia in First Remission.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S222, doi. 10.1016/j.clml.2019.07.098
By:
- Jennings, Michelle;
- Chan, Onyee;
- Komrokji, Rami;
- Padron, Eric;
- Kuykendall, Andrew;
- List, Alan;
- Mishra, Asmita;
- Lancet, Jeffrey;
- Sallman, David;
- Sweet, Kendra;
- Talati, Chetasi
Publication type:
Article
Clinical Significance of MYC Oncoprotein Expression on Survival Outcome in Secondary Acute Myeloid Leukemia (sAML).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S205, doi. 10.1016/j.clml.2019.07.066
By:
- Yun, Seongseok;
- Sharma, Rohit;
- Chan, Onyee;
- Vincelette, Nicole;
- Sallman, David;
- Sweet, Kendra;
- Padron, Eric;
- Komrokji, Rami;
- Lancet, Jeffrey;
- Moscinski, Lynn;
- Cleveland, John;
- List, Alan;
- Zhang, Ling
Publication type:
Article
When Two Roads Diverge: Genetically Inspired Prognostic Scoring System (GIPSS) Outperforms DIPSS in Myelofibrosis Patients where the Two Risk Models Widely Differ.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S266, doi. 10.1016/j.clml.2018.07.183
By:
- Kuykendall, Andrew;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami
Publication type:
Article
RADIUS-X: An Expanded Treatment Protocol for Midostaurin in Combination with Standard Chemotherapy in Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S202, doi. 10.1016/j.clml.2018.07.053
By:
- Roboz, Gail;
- Strickland, Stephen;
- Litzow, Mark;
- Dalovisio, Andrew;
- Perl, Alexander;
- Bonifacio, Gaetano;
- Haines, Kelly;
- Barbera, Alysha;
- Purkayastha, Das;
- Sweet, Kendra
Publication type:
Article
Hypomethylating Agents Versus Intensive Chemotherapy in Older Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S201, doi. 10.1016/j.clml.2018.07.051
By:
- Talati, Chetasi;
- Kuykendall, Andrew;
- Al Ali, Najla;
- Kim, Jongphil;
- Sehovic, Marina;
- Sallman, David;
- List, Alan F.;
- Komrokji, Rami;
- Extermann, Martine;
- Djulbegovic, Benjamin;
- Sweet, Kendra;
- Lancet, Jeffrey
Publication type:
Article
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.
Published in:
2017
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Al Ali, Najla;
- Sweet, Kendra;
- Padron, Eric;
- Sallman, David A.;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Zuckerman, Kenneth S.;
- Komrokji, Rami S.
Publication type:
journal article
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.
Published in:
2017
By:
- Mirza, Abu-Sayeef;
- Lancet, Jeffrey E.;
- Sweet, Kendra;
- Padron, Eric;
- Pinilla-Ibarz, Javier;
- Nardelli, Lisa;
- Cubitt, Christopher;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
State of the Art Update and Next Questions: Acute Myeloid Leukemia.
Published in:
2017
By:
- Sweet, Kendra;
- Lancet, Jeffrey
Publication type:
journal article

Found: 71